PMID: 15247556Jul 13, 2004Paper

Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Michael L LimAngela D M Kashuba

Abstract

Lopinavir/ritonavir (LPV/RTV) is a CYP3A4 inhibitor and substrate; it also may induce cytochrome P-450 (CYP) isozymes. Phenytoin (PHT) is a CYP3A4 inducer and CYP2C9/CYP2C19 substrate. This study quantified the pharmacokinetic (PK) drug interaction between LPV/RTV and PHT. Open-label, randomized, multiple-dose, PK study in healthy volunteers. Subjects in arm A (n = 12) received LPV/RTV 400/100 mg twice daily (BID) (days 1-10), followed by LPV/RTV 400/100 mg BID + PHT 300 mg once daily (QD) (days 11-22). Arm B (n = 12) received PHT 300 mg QD (days 1-11), followed by PHT 300 mg QD + LPV/RTV 400/100 mg BID (days 12-23). Plasma samples were collected on day 11 and day 22; PK parameters were compared by geometric mean ratio (GMR, day 22:day 11). P values <0.05 were considered significant. Following PHT addition, LPV area under the concentration-time curve (AUC0-12h) decreased from 70.9 +/-37.0 to 49.6 +/- 25.1 microg.h/mL (GMR 0.67, P = 0.011) and C0h decreased from 6.0 +/- 3.2 to 3.6 +/- 2.3 microg/mL (GMR 0.54, P = 0.001). Following LPV/RTV addition, PHT AUC0-24h decreased from 191.0+/-89.2 to 147.8+/-104.5 microg.h/mL (GMR 0.69, P = 0.009) and C0h decreased from 7.0+/-4.0 to 5.3+/-4.1 microg/mL (GMR 0.66, P = 0.033). Concomitant ...Continue Reading

References

Jun 1, 1990·Archives of Neurology·M C WongD R Labar
Jan 7, 1999·The Annals of Pharmacotherapy·K R KnoellE S Cousins
Jul 3, 1999·Pharmacotherapy·E P AcostaC V Fletcher
Oct 6, 1999·AIDS·G Newshan, P Tsang
Apr 20, 2000·The Annals of Pharmacotherapy·P W HugenY A Hekster
Jul 25, 2000·Pharmacotherapy·Y KatoS R Kayser
Oct 6, 2000·Clinical Neuropharmacology·A Berbel GarciaM Toledo Heras
Feb 24, 2001·The Annals of Pharmacotherapy·J Mateu-de AntonioA Carmona
Mar 29, 2001·The New England Journal of Medicine·S C Piscitelli, K D Gallicano
Apr 12, 2001·The New England Journal of Medicine·T R Browne, G L Holmes
Aug 15, 2001·Clinical Pharmacology and Therapeutics·R B KimG R Wilkinson
Feb 5, 2002·CNS Drugs·Frank Romanelli, Melody Ryan
Mar 23, 2002·The Pharmacogenomics Journal·R KerbU Brinkmann
May 11, 2002·AIDS·John D BaxterUNKNOWN CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS
Jun 28, 2002·The New England Journal of Medicine·Sharon WalmsleyUNKNOWN M98-863 Study Team
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Nanna B FinnerupTroels S Jensen
Nov 19, 2002·Annals of Internal Medicine·Vincenza SnowUNKNOWN American College of Physicians-American Society of Internal Medicine
Jan 28, 2003·Therapeutic Drug Monitoring·David M BurgerUNKNOWN ATHENA Study Group
Aug 15, 2003·The Journal of Antimicrobial Chemotherapy·J FordD J Back
Sep 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Johanna WeissWalter Emil Haefeli
Jan 20, 2004·The Journal of Clinical Psychiatry·Paul E Keck, Susan L McElroy

❮ Previous
Next ❯

Citations

Jul 12, 2008·Archives of Toxicology·Olavi PelkonenHannu Raunio
Mar 30, 2006·Current Treatment Options in Neurology·Cheryl A Jay
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah M RobertsonJoAnn M Mican
Jan 15, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stefano BonoraGiovanni Di Perri
Aug 4, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kristin H BusseScott R Penzak
May 18, 2011·AIDS Research and Therapy·Jason F OkuliczUNKNOWN Infectious Disease Clinical Research Program (IDCRP) HIV Working Group
Aug 19, 2007·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Christine A HughesLilly J Miedzinski
Feb 4, 2014·Cancer Chemotherapy and Pharmacology·Michelle A RudekJohn F Deeken
Feb 3, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Tamsin A KnoxDavid J Greenblatt
Dec 7, 2007·Drug Metabolism Reviews·Yi-Tong LiuHong-Guang Xie
Jun 7, 2005·Expert Opinion on Drug Safety·Martin Vogel, Jürgen K Rockstroh
May 1, 2010·Expert Opinion on Drug Discovery·Masashi HonmaHiroshi Suzuki
Jan 22, 2008·Current Medical Research and Opinion·Sarah M RobertsonScott R Penzak
May 17, 2011·The Lancet Oncology·Michelle A RudekRichard F Ambinder
Sep 21, 2010·General Hospital Psychiatry·Thorleif EtgenThomas Freudenberger
Apr 29, 2008·Journal of Clinical Pharmacology·Cheri E KleinGeorge J Hanna
Jan 10, 2012·Epilepsia·Gretchen L BirbeckUNKNOWN Ad Hoc Task Force Of The Commission On Therapeutic Strategies Of The International League Against Epilepsy
Sep 29, 2012·Epilepsia·Martin J BrodieDieter Schmidt
Jun 4, 2015·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Andrew StolbachPaul Pham
Nov 16, 2007·Expert Opinion on Pharmacotherapy·Sarah M RobertsonAlice Pau
Mar 30, 2010·Journal of Pain & Palliative Care Pharmacotherapy·Katherine M Juba, David Weiland
Jul 28, 2016·Epilepsy Research·Claudia Stöllberger, Josef Finsterer
Aug 10, 2005·Expert Opinion on Pharmacotherapy·Oriol ManuelPhilip E Tarr
Jun 26, 2008·The Annals of Pharmacotherapy·Michelle M FoisyChristine A Hughes
Mar 11, 2005·Expert Opinion on Pharmacotherapy·Sarah M RobertsonAlice K Pau
Jan 26, 2007·Clinical Pharmacology and Therapeutics·P L M van GiersbergenJ Dingemanse
Nov 6, 2012·Expert Review of Clinical Pharmacology·Janne Hukkanen
Oct 12, 2018·Current Neurology and Neuroscience Reports·Jorge J Asconapé
May 7, 2020·European Heart Journal. Acute Cardiovascular Care·Niyada NaksukThoetchai Bee Peeraphatdit
Nov 21, 2020·British Journal of Clinical Pharmacology·Vincent L M YipMunir Pirmohamed
Sep 12, 2020·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Georgios MavraganisMeletios-Athanasios Dimopoulos
Nov 23, 2020·The Journal of Antimicrobial Chemotherapy·Etienne MeriglierFabrice Bonnet
Oct 29, 2020·Archives of Toxicology·Jukka HakkolaOlavi Pelkonen
Mar 19, 2021·Frontiers in Neurology·Chen-Jui HoMeng-Han Tsai
Dec 7, 2007·Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria·P AmarilesM J Faus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.